Exelon CorporationEXCNASDAQ
LOADING
|||

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
16 analysts·Moderate coverage
44%
Rating Distribution
Strong Buy
00%
Buy
744%
Hold
744%
Sell
213%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 17% higher.

Bear Case
$39.00
-10%
Consensus
$50.86
+17%
Bull Case
$57.00
+32%
Price Range16 analysts
Low
Consensus
High
$39.00
$57.00
Current Target
Current Price
$43.30
Upside to Target
$7.56

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$2.83(12 analysts)
P/E16x
Current: 15.5x
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+2.61%
EPS+6.31%
FY2028
Rev+1.89%
EPS+6.21%
FY2029
Rev+2.58%
EPS+5.93%

Earnings Surprises

Beat rate:67%(8/12 quarters)
Avg surprise:+5.0%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 7, 2026RBC Capital
Exelon resumed with a Sector Perform at RBC Capital
Target:$51.00
+16.3%from $43.84
Dec 17, 2025UBS
Exelon price target lowered to $48 from $49 at UBS
Target:$48.00
+9.7%from $43.76
Dec 12, 2025KeyBanc
Exelon price target lowered to $39 from $42 at KeyBanc
Target:$39.00
-9.5%from $43.10
Nov 20, 2025Morgan Stanley
Exelon price target lowered to $52 from $53 at Morgan Stanley
Target:$52.00
+14.3%from $45.48
Oct 22, 2025Morgan Stanley
Exelon price target raised to $53 from $49 at Morgan Stanley
Target:$53.00
+9.6%from $48.34
Oct 15, 2025Jefferies
Exelon price target raised to $57 from $52 at Jefferies
Target:$57.00
+19.3%from $47.79
Oct 15, 2025KeyBanc
Exelon price target raised to $42 from $37 at KeyBanc
Target:$42.00
-11.4%from $47.38
Oct 15, 2025Jefferies
Exelon price target raised to $59 from $52 at Jefferies
Target:$59.00
+24.5%from $47.38
Oct 14, 2025Barclays
Exelon price target raised to $52 from $48 at Barclays
Target:$52.00
+11.0%from $46.85
Oct 10, 2025UBS
Exelon price target raised to $50 from $48 at UBS
Target:$50.00
+7.2%from $46.66
Oct 6, 2025Evercore ISI
Exelon initiated with an Outperform at Evercore ISI
Target:$57.00
+24.8%from $45.69
Apr 22, 2025Guggenheim
Exelon price target raised to $47 from $46 at Guggenheim
Target:$47.00
-0.8%from $47.37
Sep 19, 2024Jefferies
Exelon initiated with a Buy at Jefferies
Target:$46.00
+17.1%from $39.29
May 3, 2024BMO Capital
Exelon (EXC) PT Raised to $42 at BMO Capital
Target:$42.00
+10.8%from $37.89
Apr 1, 2024Wolfe Research
Exelon (EXC) PT Raised to $40 at Wolfe Research
Target:$40.00
+6.5%from $37.57
Mar 20, 2024Argus Research
Argus Defends Exelon (EXC): 'Recent selloff creates opportunity as rate changes drive growth'
Target:$45.00
+23.1%from $36.56
Jan 10, 2024Mizuho Securities
Mizuho Securities Upgrades Exelon (EXC) to Buy, 'Average growth rate should yield an average multiple'
Target:$39.00
+6.4%from $36.64
Dec 15, 2022Morgan Stanley
Morgan Stanley Maintains Overweight on Exelon, Raises Price Target to $49
Target:$49.00
+15.6%from $42.38
Nov 11, 2022Morgan Stanley
Morgan Stanley Maintains Overweight on Exelon, Raises Price Target to $46
Target:$46.00
+18.7%from $38.75
Apr 27, 2022Wells Fargo
Wells Fargo Maintains Equal-Weight on Exelon, Raises Price Target to $52
Target:$52.00
+7.4%from $48.42
Apr 20, 2022Morgan Stanley
Morgan Stanley Maintains Overweight on Exelon, Raises Price Target to $54
Target:$54.00
+7.5%from $50.23
Feb 3, 2022Goldman Sachs
Exelon downgraded to Neutral from Buy at Goldman Sachs
Target:$44.00
+1.3%from $43.43
Feb 3, 2022Wells Fargo
Exelon downgraded to Equal Weight from Overweight at Wells Fargo
Target:$45.00
+3.6%from $43.43
Feb 3, 2022RBC Capital
Exelon downgraded to Sector Perform from Outperform at RBC Capital
Target:$46.00
+5.9%from $43.43
Feb 2, 2022Vertical Research
Exelon downgraded to Hold from Buy at Vertical Research
Target:$45.00
+5.9%from $42.51